Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation

INTRODUCTION: Widespread use of generic drugs is considered to be indispensable if reductions in total health care costs are to be achieved, but the market share of such drugs remains low. In general, generic drugs have the same active ingredients as brand-name drugs, but this is not always the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Nobuaki, Yamane, Hiromichi, Hotta, Katsuyuki, Fujii, Hiromi, Isozaki, Hideko, Honda, Yoshihiro, Yamagishi, Tomoko, Kubo, Toshio, Tanimoto, Mitsune, Kiura, Katsuyuki, Takigawa, Nagio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262375/
https://www.ncbi.nlm.nih.gov/pubmed/25584019
http://dx.doi.org/10.2147/DDDT.S71419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262375/
https://www.ncbi.nlm.nih.gov/pubmed/25584019
http://dx.doi.org/10.2147/DDDT.S71419

Ejemplares similares